Obstetrics & Gynecology
MD, Albert Einstein College of Medicine
Montefiore Medical Center
Fellowship, Reproductive Endocrinology & Infertility
Mount Sinai Hospital
Beilin Y, Bodian C, Mukherjee T, Andres L, Vincent RD, Hock DL, Sparks AE, Munson AK, Minnich ME, Steinkampf MP, Christman GM, McKay RS, Eisenkraft J. The use of propofol, nitrous oxide, or isoflurane does not affect the reproductive success rate following gamete intrafallopian transfer (GIFT): a mul. Anesthesiology 1999 Jan; 90(1): 36-41.
Ali SS, Elliott WH. Bile acids. XLVII. 12alpha-Hydroxylation of precursors of allo bile acids by rabbit liver microsomes. Biochimica et biophysica acta 1975 Nov; 409(2).
Alekseeva IG, Lapina GP, Tulovskaia ZD, Izmaĭlova VN. [Structure formation in interphase adsorption layers of lysozyme at liquid boundaries]. Biofizika; 20(4).
Rose AH. Growth and handling of yeasts. Methods in cell biology 1975; 12.
Donahoo CA. If you like variety, become an orthopedic surgeon's assistant. Nursing 1976 Jan; 6(1).
Caras I, Shapiro B. Partial purification and properties of microsomal phosphatidate phosphohydrolase from rat liver. Biochimica et biophysica acta 1975 Nov; 409(2).
Smith RJ, Bryant RG. Metal substitutions incarbonic anhydrase: a halide ion probe study. Biochemical and biophysical research communications 1975 Oct; 66(4).
A prospective, randomized, placebo, controlled study on the effect of cyclic intermittent etidronate therapy on bone mineral density changes associated with six months of gonadotropin releasing hormone agonist treatment.. Am J Obstet Gynecol 1996; 8.
The effect of prolonged gonadotropin releasing hormone agonist therapy on the histopathology of uterine leiomyomata. . Journal of Gynecologic Surgery;.
Prophylactic albumin for severe ovarian hyperstimulation syndrome.. Fertil Steril (Letter) 1996 July;.
The effect of hydrosalpinx fluid on murine embryogenesis: a case for prophylactic salpingectomy. . Fertil Steril 1996; 66:851-3.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Mukherjee has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.